Repligen Corporation ($RGEN) Stock Forecast: Down 6.0% Today

What is Repligen Corporation?

A company in the Medical Biomedical and Genetics sector, Repligen (RGEN), experienced significant bearish movement in the market recently.

Why is Repligen Corporation going down?

RGEN stock is down 6.0% on Oct 28, 2025 14:15

• Despite exceeding earnings and revenue forecasts in Q3, Repligen (RGEN) faced a bearish trend, potentially triggering investor sell-off.
• Market sentiment towards Repligen may have been impacted by comparisons with Alkermes (ALKS) in terms of value, contributing to the stock's bearish performance.
• Investors seemed to have responded to the positive earnings results by selling shares to secure profits, resulting in a temporary dip in the stock's value.

RGEN Price Chart

RGEN Technical Analysis

RGEN News

Repligen ( RGEN ) Q3 Earnings and Revenues Surpass Estimates

Repligen (RGEN) delivered earnings and revenue surprises of +9.52% and +4.18%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

https://www.zacks.com/stock/news/2778716/repligen-rgen-q3-earnings-and-revenues-surpass-estimates

ALKS vs. RGEN: Which Stock Is the Better Value Option?

Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Alkermes ( ALKS Quick QuoteALKS - ) or Repligen ( RGEN Quick QuoteRGEN - ) . But which of these two stocks offers value investors a better bang for their buck right now?

https://www.zacks.com/stock/news/2773324/alks-vs-rgen-which-stock-is-the-better-value-option

Trending Today

Reddit Inc ($RDDT) Stock Forecast: Down 6.6% Today

Wingstop Inc. ($WING) Stock Forecast: Down 9.9% Today

Align Technology Inc. ($ALGN) Stock Forecast: Up 5.4% Today

Duolingo Inc. ($DUOL) Stock Forecast: Down 5.0% Today

SoFi Technologies Inc. ($SOFI) Stock Forecast: Down 5.3% Today

KLA-Tencor Corporation ($KLAC) Stock Forecast: Down 5.5% Today

ZCash ($ZEC) Crypto Forecast: Down 7.7% Today

Shiba Inu ($SHIB) Crypto Forecast: Down 8.2% Today

Bitcoin Cash ($BCH) Crypto Forecast: Down 5.5% Today

Upstart Holdings Inc. ($UPST) Stock Forecast: Down 8.8% Today

Repligen Corporation Price History

16.03.2025 - RGEN Stock was up 5.7%

• Comparisons between GMAB and RGEN potentially piqued investor interest in RGEN, resulting in increased buying activity.
• The upcoming first quarter financial results announcement for 2025 likely generated excitement and positivity among investors, leading to a rise in the company's stock price.
• The market's favorable reception of RGEN's emphasis on bioprocessing products and services within the life sciences sector may have bolstered the bullish movement.

07.04.2025 - RGEN Stock was down 6.5%

• Repligen Corporation's stock, RGEN, exhibited a decline today, possibly attributed to profit-taking by investors following a period of strong growth.
• A comparative analysis between QGEN and RGEN could have triggered uncertainty among investors, leading to the selling pressure on RGEN shares.
• The anticipation surrounding the upcoming investor conferences might have prompted some investors to reassess their positions in RGEN, contributing to the downward trend.
• In summary, today's bearish movement in RGEN could be linked to profit-taking, comparative analysis with QGEN, and investor sentiment around the forthcoming conferences.

22.07.2025 - RGEN Stock was up 5.4%

• The company revealed its involvement in three forthcoming investor conferences, hinting at possible growth prospects.
• Repligen's participation in these conferences could be perceived as a tactic to appeal to more investors and highlight its advancements in bioprocessing technology.
• Investors might interpret Repligen's proactive engagement with the investment community as a vote of confidence in its future potential, potentially attracting more buyers and boosting the stock price.

06.04.2025 - RGEN Stock was down 6.6%

• Despite reporting strong Q1 earnings and raising revenue guidance for 2025, the market may have had higher expectations, resulting in a sell-off.
• Investors might be favoring QIAGEN (QGEN) over Repligen (RGEN) as a more attractive value stock, impacting RGEN's stock price.
• The bearish movement could be due to profit-taking by traders who had bought the stock in anticipation of positive earnings, causing a temporary decline in the stock price.

30.03.2025 - RGEN Stock was down 5.0%

• Despite exceeding expectations in earnings and revenue for Q1, Repligen (RGEN) faced a significant bearish trend in its stock.
• There is a possibility that external factors or guidance provided by the company led to an exaggerated market reaction, resulting in a sell-off.
• Investor apprehension regarding challenges in the biotech industry may have contributed to the negative outlook on Repligen's stock.
• Profit-taking or a general market downturn could have influenced the bearish movement, overshadowing Repligen's positive earnings report.

22.03.2025 - RGEN Stock was up 6.8%

• Anticipation of strong earnings growth in the upcoming report is likely boosting investor confidence in Repligen (RGEN) and contributing to the positive market movement.
• Comparisons of value between Repligen (RGEN) and another company may have attracted investor interest towards Repligen (RGEN), resulting in increased buying activity and driving the stock price up.
• Positive market sentiment and expectations of a favorable earnings report are possibly fueling a bullish trend in Repligen (RGEN) today.

01.07.2025 - RGEN Stock was down 5.4%

• The stock's downward trend, which has persisted for over 1400 days, may have contributed to the bearish movement.
• While Repligen announced a strategic partnership with Novasign for bioprocessing digitalization, investors appeared more concerned about the long-term downtrend and associated risks.
• Market sentiment appears to have been influenced by technical analysis and Adhishthana principles, signaling ongoing weakness in the stock and leading to today's bearish movement.

17.06.2025 - RGEN Stock was up 5.0%

• Repligen Corporation announced the upcoming release of its second-quarter 2025 financial results, creating anticipation and positive sentiment among investors.
• The market might be reacting positively to the potential growth and performance indicators that could be revealed during the earnings call.
• Investors seem optimistic about Repligen's future prospects, leading to increased buying activity and driving the stock price higher.
• The strong bullish movement could be a reflection of confidence in Repligen's business strategies and financial health, as hinted by the upcoming financial report.

03.05.2025 - RGEN Stock was up 5.2%

• Upward trends are noticeable among options traders for Repligen (RGEN) stock, reflecting a positive market sentiment.
• The increased engagement in the options market implies expectations of favorable updates or progress related to Repligen's operations.
• This upsurge in positive activity may be linked to possible future collaborations, product introductions, or robust financial results, stimulating investor confidence and elevating the stock value.

23.09.2025 - RGEN Stock was up 5.4%

• Despite initial expectations of a decline in Q3 earnings, Repligen (RGEN) demonstrated a strong bullish performance, potentially signaling investor focus on other positive aspects.
• A comparison of Repligen (RGEN) with Alkermes (ALKS) may have contributed to increased investor interest, supporting the upward momentum in the market.
• Market sentiment towards Repligen (RGEN) potentially improved due to factors beyond earnings, such as anticipated growth opportunities or strategic advancements.

29.03.2025 - RGEN Stock was down 5.1%

• Despite Repligen (RGEN) topping Q1 earnings and revenue estimates, the stock experienced a bearish movement, indicating that the market may have had higher expectations.
• The anticipation of a potential beat in the next earnings report might have already been priced into the stock, leading to a sell-off after the strong performance in the previous quarter.
• Investors might be profit-taking after the recent positive surprises, causing a temporary dip in the stock price despite the company's solid financial results.

28.09.2025 - RGEN Stock was down 6.0%

• Despite exceeding earnings and revenue forecasts in Q3, Repligen (RGEN) faced a bearish trend, potentially triggering investor sell-off.
• Market sentiment towards Repligen may have been impacted by comparisons with Alkermes (ALKS) in terms of value, contributing to the stock's bearish performance.
• Investors seemed to have responded to the positive earnings results by selling shares to secure profits, resulting in a temporary dip in the stock's value.